On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Fen Du

ResearcherPublications, citations & collaboration network

Fen Du is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Fen Du have?

ScholarIQindexed works

Fen Du has 22 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Fen Du have?

ScholarIQcitation count

Fen Du has 195 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Fen Du?

ScholarIQh-index

Fen Du has an h-index of 9 in OpenAlex.

What is the i10-index of Fen Du?

ScholarIQi10-index

Fen Du has an i10-index of 9 in OpenAlex.

What is the OpenAlex record for Fen Du?

ScholarIQopenalex

The OpenAlex for Fen Du is on the source record.

What are the most-cited papers on Fen Du?

ScholarIQmost cited works
Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics
Mengjie Yu, Shuilin Sun, Jiangqing Yu, Fen Du, Shouhua Zhang, Wenlong Yang, Juhua Xiao, Baogang Xie
Journal of Proteome Research. 201840 Citations
Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China
Yan Xu, Mao Ningying, Viktor Chirikov, Fen Du, Yu‐Chen Yeh, Li Liu, Ruiqi Liu, Xin Gao
Clinical Drug Investigation. 201923 CitationsOPEN ACCESS
Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries
Omer Zaidi, Fen Du, Zhaoli Tang, Sandipan Bhattacharjee, Kristin Pareja
BMC Nephrology. 202423 CitationsOPEN ACCESS
<i>ABCB1</i>3435TT and<i>ABCG2</i>421CC genotypes were significantly associated with longer progression-free survival in Chinese breast cancer patients
Wanjun Li, Dan Zhang, Fen Du, Xuemei Xing, Ying Wu, Dong Xiao, Ming Liang, Zhigang Fan, Peng Zhao, Tao Liu, Guoyin Li
Oncotarget. 201719 CitationsOPEN ACCESS
&lt;p&gt;FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC&lt;/p&gt;
Dan Zhang, Lili Han, Fen Du, Xiaomeng Liu, Jin Li, Huihui Wang, Minghui Song, Zeng Li, Guo-yin Li
OncoTargets and Therapy. 201917 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial